Back to Search
JAMES MCCRACKEN, MD
MD
Psychiatry Physician
NPI: 1568495026IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
C41912(CA)
CMS Specialties
PrimaryPSYCHIATRY
Education
BAYLOR COLLEGE OF MEDICINE
Class of 1980
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
PMID 41342306·Cochrane Database Syst Rev·2025
1-meta
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).
PMID 37811711·Cochrane Database Syst Rev·2023
1-meta
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
PMID 36971690·Cochrane Database Syst Rev·2023
1-meta
Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children With Attention-Deficit/Hyperactivity Disorder.
PMID 35963559·J Am Acad Child Adolesc Psychiatry·2023
2-rct
Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory in Attention-Deficit/Hyperactivity Disorder.
PMID 35963558·J Am Acad Child Adolesc Psychiatry·2023
2-rct
Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.
PMID 27483130·J Child Adolesc Psychopharmacol·2016
4-observational
Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.
PMID 27453081·J Am Acad Child Adolesc Psychiatry·2016
2-rct
Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.
PMID 27453080·J Am Acad Child Adolesc Psychiatry·2016
2-rct
Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.
PMID 27453079·J Am Acad Child Adolesc Psychiatry·2016
4-observational
A prospective open trial of guanfacine in children with pervasive developmental disorders.
PMID 17069547·J Child Adolesc Psychopharmacol·2006
4-observational
A screen of SLC1A1 for OCD-related alleles.
PMID 19569082·Am J Med Genet B Neuropsychiatr Genet·2010
8-other
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
PMID 19182688·J Am Acad Child Adolesc Psychiatry·2009
4-observational
Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome.
PMID 18928414·J Child Adolesc Psychopharmacol·2008
3-trial
Safety and tolerability of methylphenidate in preschool children with ADHD.
PMID 17028508·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
PMID 17023870·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).
PMID 17023869·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Stimulant-related reductions of growth rates in the PATS.
PMID 17023868·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
PMID 17023867·J Am Acad Child Adolesc Psychiatry·2006
4-observational
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.
PMID 16721314·J Am Acad Child Adolesc Psychiatry·2006
8-other
Relationship of family environment and parental psychiatric diagnosis to impairment in ADHD.
PMID 16540820·J Am Acad Child Adolesc Psychiatry·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 MEDICAL PLZ
LOS ANGELES, CA 90095 - Phone
- (310) 825-9989
Quick Facts
- NPI
- 1568495026
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile